BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2023 7:03:16 AM | Browse: 231 | Download: 926
 |
Received |
|
2022-12-05 09:58 |
|
Peer-Review Started |
|
2022-12-05 09:58 |
|
First Decision by Editorial Office Director |
|
2022-12-26 03:23 |
|
Return for Revision |
|
2022-12-26 03:23 |
|
Revised |
|
2023-01-04 15:37 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-01-16 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-01-16 10:31 |
|
Articles in Press |
|
2023-01-16 10:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-01-30 09:33 |
|
Publish the Manuscript Online |
|
2023-02-14 07:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian-Jing Liang, Wen-Jing Feng, Ru Li, Run-Tao Xu and Yu-Long Liang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yu-Long Liang, MM, Associate Chief Physician, Associate Professor, Department of General Surgery, the Third Hospital of Hebei Medical University, 139 Ziqiang Road, Qiaoxi District, Shijiazhuang 050051, Hebei Province, China. yulongliang2020@163.com |
| Key Words |
Thyroid-stimulating hormone; Thyroid cancer; Clinical efficacy; Safety profile |
| Core Tip |
Thyroid carcinoma (TC) is the most common cancer in the endocrine system. It has been established that thyroid-stimulating hormone (TSH) stimulates the growth and development of thyroid malignancy, and a higher serum TSH level is associated with the incidence of thyroid cancer and an advanced tumor stage. This study aims to explore the clinical value of TSH in regulating the progress of TC, which can provide a new direction for thyroid therapy. |
| Publish Date |
2023-02-14 07:03 |
| Citation |
Liang JJ, Feng WJ, Li R, Xu RT, Liang YL. Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer. World J Clin Cases 2023; 11(5): 1058-1067 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i5/1058.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i5.1058 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
